{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:25:06Z","timestamp":1787185506837,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020.01\/0080"],"award-info":[{"award-number":["2020.01\/0080"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020.01\/0080"],"award-info":[{"award-number":["2020.01\/0080"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020.01\/0080"],"award-info":[{"award-number":["2020.01\/0080"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020.01\/0080"],"award-info":[{"award-number":["2020.01\/0080"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020.01\/0080"],"award-info":[{"award-number":["2020.01\/0080"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020.01\/0080"],"award-info":[{"award-number":["2020.01\/0080"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SFI-PD-Ukraine-00014576"],"award-info":[{"award-number":["SFI-PD-Ukraine-00014576"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SFI-PD-Ukraine-00014576"],"award-info":[{"award-number":["SFI-PD-Ukraine-00014576"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SFI-PD-Ukraine-00014576"],"award-info":[{"award-number":["SFI-PD-Ukraine-00014576"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SFI-PD-Ukraine-00014576"],"award-info":[{"award-number":["SFI-PD-Ukraine-00014576"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SFI-PD-Ukraine-00014576"],"award-info":[{"award-number":["SFI-PD-Ukraine-00014576"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein represents a key antigen for vaccine development due to its critical role in the ACE2 receptor recognition. Yeast-based expression systems, particularly\n                      <jats:italic>Komagataella phaffii<\/jats:italic>\n                      , offer scalable and cost-effective platforms for recombinant protein production. In addition to secretion, cell surface display provides an alternative strategy enabling direct antigen delivery, including applications via mucosal routes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, we engineered\n                      <jats:italic>K. phaffii<\/jats:italic>\n                      strains for the production of SARS-CoV-2 RBD in two formats: as a secreted recombinant protein and as a cell surface-displayed antigen using a Sag1 anchoring system. Incorporation of glycine\u2013serine linkers enhanced secretion efficiency, yielding up to 50\u00a0mg\/L of RBD, with minimal intracellular retention. Western blot analysis indicated the presence of glycosylated forms of RBD, and the recombinant protein was subsequently purified for further characterization. Surface localization of RBD was validated by immunofluorescence microscopy and quantitative fluorescence measurements. Immunogenicity studies in mice demonstrated that intraperitoneal administration of purified RBD elicited a strong humoral immune response. Importantly, sera from immunized animals efficiently inhibited spike protein binding to the Ace2 receptor, indicating potent neutralizing activity. Comparable results were obtained following oral administration of\n                      <jats:italic>K. phaffii<\/jats:italic>\n                      cells displaying RBD on their surface, demonstrating the feasibility of a whole-cell yeast-based vaccine approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A yeast-based system enabling both secretion and surface display of SARS-CoV-2 RBD has been developed. Both delivery strategies, intraperitoneal administration of the purified protein and oral administration of recombinant yeast cells, induced robust and functionally relevant immune responses in mice. These findings highlight the potential of\n                      <jats:italic>K. phaffii<\/jats:italic>\n                      as a versatile system for the development of cost-effective subunit and oral vaccine candidates.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12934-026-03043-5","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:23:36Z","timestamp":1781202216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering Komagataella phaffii for secreted and surface-displayed production of SARS-CoV-2 receptor-binding domain and its immunogenicity evaluation"],"prefix":"10.1186","volume":"25","author":[{"given":"Kostyantyn","family":"Dmytruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Dmytruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Semkiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksolana","family":"Vasylyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubov","family":"Fayura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gaffke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Podlacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Cyske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Pierzynowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Budylowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Wegrzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriy","family":"Sibirny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"1","key":"3043_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.23750\/abm.v91i1.9397","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157\u201360. https:\/\/doi.org\/10.23750\/abm.v91i1.9397.","journal-title":"Acta Biomed"},{"issue":"7","key":"3043_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S2213-2600(23)00217-5","volume":"11","author":"T Burki","year":"2023","unstructured":"Burki T. WHO ends the COVID-19 public health emergency. Lancet Respir Med. 2023;11(7):588. https:\/\/doi.org\/10.1016\/S2213-2600(23)00217-5.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"3043_CR3","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1097\/JS9.0000000000000521","volume":"109","author":"K Cheng","year":"2023","unstructured":"Cheng K, Wu C, Gu S, Lu Y, Wu H, Li C. WHO declares the end of the COVID-19 global health emergency: lessons and recommendations from the perspective of ChatGPT\/GPT-4. Int J Surg. 2023;109(9):2859\u201362. https:\/\/doi.org\/10.1097\/JS9.0000000000000521.","journal-title":"Int J Surg"},{"issue":"6","key":"3043_CR4","doi-asserted-by":"publisher","first-page":"e0142623","DOI":"10.1128\/mbio.01426-23","volume":"14","author":"JP Townsend","year":"2023","unstructured":"Townsend JP, Hassler HB, Lamb AD, Sah P, Alvarez Nishio A, Nguyen C, et al. Seasonality of endemic COVID-19. mBio. 2023;14(6):e0142623. https:\/\/doi.org\/10.1128\/mbio.01426-23.","journal-title":"mBio"},{"issue":"175","key":"3043_CR5","doi-asserted-by":"publisher","first-page":"240222","DOI":"10.1183\/16000617.0222-2024","volume":"34","author":"G Zhou","year":"2025","unstructured":"Zhou G, Dael N, Verweij S, Balafas S, Mubarik S, Oude Rengerink K, et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies. Eur Respir Rev. 2025;34(175):240222. https:\/\/doi.org\/10.1183\/16000617.0222-2024.","journal-title":"Eur Respir Rev"},{"key":"3043_CR6","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.csbj.2021.04.061","volume":"19","author":"A Nagy","year":"2021","unstructured":"Nagy A, Alhatlani B. An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J. 2021;19:2508\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2021.04.061.","journal-title":"Comput Struct Biotechnol J"},{"issue":"18","key":"3043_CR7","doi-asserted-by":"publisher","first-page":"e2025622118","DOI":"10.1073\/pnas.2025622118","volume":"118","author":"DLNF Maeda","year":"2021","unstructured":"Maeda DLNF, Tian D, Yu H, Dar N, Rajasekaran V, Meng S, et al. Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model. Proc Natl Acad Sci USA. 2021;118(18):e2025622118. https:\/\/doi.org\/10.1073\/pnas.2025622118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3043_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41541-021-00321-8","volume":"6","author":"Q Jia","year":"2021","unstructured":"Jia Q, Bielefeldt-Ohmann H, Maison RM, Masle\u0161a-Gali\u0107 S, Cooper SK, Bowen RA, et al. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 membrane and nucleocapsid proteins protects against severe COVID-19-like disease in hamsters. NPJ Vaccines. 2021;6(1):47. https:\/\/doi.org\/10.1038\/s41541-021-00321-8.","journal-title":"NPJ Vaccines"},{"issue":"1","key":"3043_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12934-023-02100-7","volume":"22","author":"IC Hwang","year":"2023","unstructured":"Hwang IC, Valeriano VD, Song JH, Pereira M, Oh JK, Han K, et al. Mucosal immunization with Lactiplantibacillus plantarum displaying recombinant SARS-CoV-2 epitopes induces humoral and mucosal immune responses in mice. Microb Cell Fact. 2023;22(1):96. https:\/\/doi.org\/10.1186\/s12934-023-02100-7.","journal-title":"Microb Cell Fact"},{"issue":"1","key":"3043_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12934-021-01584-5","volume":"20","author":"T Gao","year":"2021","unstructured":"Gao T, Ren Y, Li S, Lu X, Lei H. Immune response induced by oral administration of a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice. Microb Cell Fact. 2021;20(1):95. https:\/\/doi.org\/10.1186\/s12934-021-01584-5.","journal-title":"Microb Cell Fact"},{"issue":"5","key":"3043_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/idr17050104","volume":"17","author":"LS de Mac\u00eado","year":"2025","unstructured":"de Mac\u00eado LS, Espinoza BCF, Inven\u00e7\u00e3o MDCV, Pinho SS, Leal LRS, Silva MEDS, et al. Oral immunization with yeast-surface display of SARS-CoV-2 antigens in Pichia pastoris induces humoral responses in BALB\/c mice. Infect Dis Rep. 2025;17(5):104. https:\/\/doi.org\/10.3390\/idr17050104.","journal-title":"Infect Dis Rep"},{"key":"3043_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.csbj.2023.02.007","volume":"21","author":"A Vetr\u00e1kov\u00e1","year":"2023","unstructured":"Vetr\u00e1kov\u00e1 A, Chovanov\u00e1 RK, Rechtor\u00edkov\u00e1 R, Kraj\u010d\u00edkov\u00e1 D, Bar\u00e1k I. Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein. Comput Struct Biotechnol J. 2023;21:1550\u20136. https:\/\/doi.org\/10.1016\/j.csbj.2023.02.007.","journal-title":"Comput Struct Biotechnol J"},{"issue":"8","key":"3043_CR13","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.3390\/ijms26083615","volume":"26","author":"C Si","year":"2025","unstructured":"Si C, Bai J, Li Y, Li Y, Liu Y, Zhou X, et al. Establishment of a novel platform for developing oral vaccines based on yeast spore surface display. Int J Mol Sci. 2025;26(8):3615. https:\/\/doi.org\/10.3390\/ijms26083615.","journal-title":"Int J Mol Sci"},{"key":"3043_CR14","doi-asserted-by":"publisher","first-page":"1150412","DOI":"10.3389\/fmicb.2023.1150412","volume":"14","author":"N Austriaco","year":"2023","unstructured":"Austriaco N. Yeast oral vaccines against infectious diseases. Front Microbiol. 2023;14:1150412. https:\/\/doi.org\/10.3389\/fmicb.2023.1150412.","journal-title":"Front Microbiol"},{"key":"3043_CR15","doi-asserted-by":"publisher","first-page":"794742","DOI":"10.3389\/fbioe.2021.794742","volume":"9","author":"KV Teymennet-Ram\u00edrez","year":"2022","unstructured":"Teymennet-Ram\u00edrez KV, Mart\u00ednez-Morales F, Trejo-Hern\u00e1ndez MR. Yeast surface display system: strategies for improvement and biotechnological applications. Front Bioeng Biotechnol. 2022;9:794742.","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"3043_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/bioengineering8090119","volume":"8","author":"S de S\u00e1 Magalh\u00e3es","year":"2021","unstructured":"de S\u00e1 Magalh\u00e3es S, Keshavarz-Moore E. Pichia pastoris (Komagataella phaffii) as a cost-effective tool for vaccine production for LMICs. Bioeng (Basel). 2021;8(9):119. https:\/\/doi.org\/10.3390\/bioengineering8090119.","journal-title":"Bioeng (Basel)"},{"key":"3043_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fbioe.2019.00262","volume":"7","author":"SA van der Hoek","year":"2019","unstructured":"van der Hoek SA, Darbani B, Zugaj KE, Prabhala BK, Biron MB, Randelovic M, et al. Engineering Saccharomyces cerevisiae for production of L-(+)-ergothioneine. Front Bioeng Biotechnol. 2019;7:262. https:\/\/doi.org\/10.3389\/fbioe.2019.00262.","journal-title":"Front Bioeng Biotechnol"},{"issue":"12","key":"3043_CR18","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1007\/s00253-014-5732-5","volume":"98","author":"M Ahmad","year":"2014","unstructured":"Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in Pichia pastoris: recent achievements and perspectives. Appl Microbiol Biotechnol. 2014;98(12):5301\u201317. https:\/\/doi.org\/10.1007\/s00253-014-5732-5.","journal-title":"Appl Microbiol Biotechnol"},{"key":"3043_CR19","doi-asserted-by":"publisher","first-page":"foaf010","DOI":"10.1093\/femsyr\/foaf010","volume":"25","author":"W Lv","year":"2025","unstructured":"Lv W, Cai M. Advancing recombinant protein expression in Komagataella phaffii: opportunities and challenges. FEMS Yeast Res. 2025;25:foaf010. https:\/\/doi.org\/10.1093\/femsyr\/foaf010.","journal-title":"FEMS Yeast Res"},{"issue":"1","key":"3043_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/biom16010116","volume":"16","author":"P Baindara","year":"2026","unstructured":"Baindara P, Dinata R, Kumar R. Yeast-based vaccine platforms: applications and insights from the COVID-19 era. Biomolecules. 2026;16(1):116. https:\/\/doi.org\/10.3390\/biom16010116.","journal-title":"Biomolecules"},{"key":"3043_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1567-1364.2010.00665.x","volume":"10","author":"A Ardiani","year":"2010","unstructured":"Ardiani A, Higgins JP, Hodge JW. Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res. 2010;10:1060\u20139. https:\/\/doi.org\/10.1111\/j.1567-1364.2010.00665.x.","journal-title":"FEMS Yeast Res"},{"issue":"1","key":"3043_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/07388551.2025.2536808","volume":"46","author":"R Kumar","year":"2026","unstructured":"Kumar R, Srivastava V, Ahmad A, Mandal SM, Baindara P. Whole recombinant yeast-based vaccines: concept, importance, issues, and future scope. Crit Rev Biotechnol. 2026;46(1):45\u201360. https:\/\/doi.org\/10.1080\/07388551.2025.2536808.","journal-title":"Crit Rev Biotechnol"},{"issue":"5","key":"3043_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/etm.2024.12511","volume":"27","author":"Y Liu","year":"2024","unstructured":"Liu Y, Lam DM, Luan M, Zheng W, Ai H. Recent development of oral vaccines. Exp Ther Med. 2024;27(5):223. https:\/\/doi.org\/10.3892\/etm.2024.12511.","journal-title":"Exp Ther Med"},{"key":"3043_CR24","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s00253-021-11259-1","volume":"105","author":"R Kumar","year":"2021","unstructured":"Kumar R, Kharbikar BN. Lyophilized yeast powder for adjuvant-free thermostable vaccine delivery. Appl Microbiol Biotechnol. 2021;105:3131\u201343.","journal-title":"Appl Microbiol Biotechnol"},{"key":"3043_CR25","unstructured":"Green M, Sambrook J. Molecular cloning: a laboratory manual. 4th Edition, Cold Spring Harbor Laboratory Press; 2012."},{"key":"3043_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1385\/0-89603-421-6:27","volume":"103","author":"JM Cregg","year":"1998","unstructured":"Cregg JM, Russell KA. Pichia protocols. Methods Mol Biol. 1998;103:27\u201340.","journal-title":"Methods Mol Biol"},{"issue":"14","key":"3043_CR27","doi-asserted-by":"publisher","first-page":"9986","DOI":"10.1074\/jbc.275.14.9986","volume":"275","author":"RJ Baerends","year":"2000","unstructured":"Baerends RJ, Faber KN, Kram AM, Kiel JA, van der Klei IJ, Veenhuis M. A stretch of positively charged amino acids at the N terminus of Hansenula polymorpha Pex3p is involved in incorporation of the protein into the peroxisomal membrane. J Biol Chem. 2000;275(14):9986\u201395. https:\/\/doi.org\/10.1074\/jbc.275.14.9986.","journal-title":"J Biol Chem"},{"key":"3043_CR28","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature. 1970;227:680\u20135.","journal-title":"Nature"},{"key":"3043_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0165-022X(84)90040-X","volume":"10","author":"J Kyhse-Andersen","year":"1984","unstructured":"Kyhse-Andersen J. Electroblotting of multiple gels: a simple apparatus for protein transfer. J Biochem Biophys Methods. 1984;10:203\u20139.","journal-title":"J Biochem Biophys Methods"},{"issue":"4","key":"3043_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/biology13040207","volume":"13","author":"M Schwarze","year":"2024","unstructured":"Schwarze M, Volke D, Rojas Echeverri JC, Schick R, Lakowa N, Gr\u00fcnewald T, et al. Influence of Mutations and N-Glycosylation Sites in the Receptor-Binding Domain (RBD) and the Membrane Protein of SARS-CoV-2 Variants of Concern on Antibody Binding in ELISA. Biology. 2024;13(4):207. https:\/\/doi.org\/10.3390\/biology13040207.","journal-title":"Biology"},{"issue":"1","key":"3043_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12934-018-1032-6","volume":"17","author":"A Pekarsky","year":"2018","unstructured":"Pekarsky A, Veiter L, Rajamanickam V, Herwig C, Gr\u00fcnwald-Gruber C, Altmann F, et al. Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison. Microb Cell Fact. 2018;17(1):183. https:\/\/doi.org\/10.1186\/s12934-018-1032-6.","journal-title":"Microb Cell Fact"},{"issue":"1","key":"3043_CR32","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1038\/s41467-021-23929-9","volume":"12","author":"C Lee","year":"2021","unstructured":"Lee C, Verma R, Byun S, Jeun EJ, Kim GC, Lee S, et al. Structural specificities of cell surface \u03b2-glucan polysaccharides determine commensal yeast mediated immuno-modulatory activities. Nat Commun. 2021;12(1):3611. https:\/\/doi.org\/10.1038\/s41467-021-23929-9.","journal-title":"Nat Commun"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12934-026-03043-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-026-03043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-026-03043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:46:14Z","timestamp":1787183174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12934-026-03043-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3043"],"URL":"https:\/\/doi.org\/10.1186\/s12934-026-03043-5","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GW is an editor of Microbial Cell Factories. The authors declare no other competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"174"}}